An update from Beyond Air ( ($XAIR) ) is now available. On March 14, 2025, Ron Bentsur resigned from the board of directors of Beyond Air, Inc., ...
Distribution agreements recently signed for France, Turkey, Romania and MoroccoLungFit PH international distribution network now includes 18 ...
The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.
Fast track was first introduced by FDA to expedite development and review of drugs to treat serious conditions lacking any FDA-approved drug,” commented Gary S. Jacob, Ph.D., Chief Executive Officer ...
Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...
Imbed Biosciences ("Imbed"), a pioneer in breakthrough wound care synthetic matrix technology, today announced the U.S. Food and Drug Administration (FDA) has approved an Investigational Device ...
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...